[{"name":"New frontiers in the management of HER2+ brain metastases (ID 749)","mode":"","is_cme":false,"info":{"presentation":"New frontiers in the management of HER2+ brain metastases <small>(ID 749)<\/small>","session":"Seattle Genetics - Industry Satellite Symposium: Improving outcomes after T-DM1 - a new horizon for HER2+ mBC patients <small>(ID 75)<\/small>","presenter":"Thomas Bachelot<small> (Lyon, France)<\/small>","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/breast2020\/persons\/photos\/49.jpg"},"playlist":[{"name":"New frontiers in the management of HER2+ brain metastases","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/75\/v\/749_2c.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/breast2020\/75\/v\/749_2c.mp4","cover":"","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/75\/v\/749_2c.vtt","thumbnails":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/breast2020\/75\/v\/749_2c-thumbnails.vtt"}]}]{"provider":"CTI","provider_live":0,"type":1,"code":"aL240dV02Vk"}